Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review
Journal of Clinical Medicine · 11.06.2025 · 14 (12) · 4128
DOI: 10.3390/jcm14124128 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.06.2025. Verfasst von Sapna Ravindranath und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Anesthesiology at Indiana University School of Medicine.
Abstract (Originalsprache)
Sugammadex represents a significant advancement in neuromuscular blockade management, enabling rapid, predictable, and highly effective reversal of steroidal neuromuscular blockers such as rocuronium and vecuronium. This review critically examines recent advances in sugammadex research, particularly over the last decade, detailing its pharmacological profile, clinical efficacy, and safety compared to traditional reversal agents, like neostigmine. Its expanding clinical applications across operating rooms, critical care units, and emergency medicine are discussed, emphasizing dosing recommendations and clinical utility in special patient populations, including individuals with renal impairment, pediatric, obstetric, and obese patients. Economic considerations are explored, highlighting sugammadex’s cost-effectiveness through reduced postoperative complications and enhanced operational efficiency, despite higher initial costs. Finally, the review outlines ongoing research directions, including emerging reversal agents, advanced neuromuscular monitoring technologies, and potential future clinical applications, underscoring sugammadex’s evolving role in improving patient safety and anesthetic practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
ORCID-Profile: Sapna Ravindranath, John Wolfe, Yatish S Ranganath
Förderung
- Department of Anesthesiology at Indiana University School of Medicine
Zitieren
APA
Ravindranath, S., Backfish-White, K., Wolfe, J., & Ranganath, Y. S. (2025). Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review. Journal of Clinical Medicine, 14(12), 4128. https://doi.org/10.3390/jcm14124128
Vancouver
Ravindranath S, Backfish-White K, Wolfe J, Ranganath YS. Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review. Journal of Clinical Medicine. 2025;14(12):4128. doi:10.3390/jcm14124128
BibTeX
@article{Ravindranath2025,
author = {Ravindranath, Sapna and Backfish-White, Kevin and Wolfe, John and Ranganath, Yatish S},
title = {Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {12},
pages = {4128},
doi = {10.3390/jcm14124128}
}
EUVIMED